Top

Published in:

01-02-2019 | Original Article

Poor Relationship Between Fractionated Exhaled Nitric Oxide and Disease Activity in Eosinophilic Esophagitis

Authors: Kimberly Johnson, Vivek Iyer, David Katzka, Karthik Ravi, Ryan Lennon, Richard Pendegraft, Debra Geno, Jeffrey Alexander

Published in: Dysphagia | Issue 1/2019

Abstract

Current eosinophilic esophagitis care requires monitoring with repeat endoscopy and biopsy, which has significant cost, risk, and inconvenience for patients. Fractionated exhaled nitric oxide testing (FeNO) is a standardized non-invasive test with proven utility in evaluation of asthma. Elevated FeNO has reported use in other eosinophilic inflammatory conditions; however, its use in eosinophilic esophagitis has not been fully evaluated. To assess the utility of FeNO in predicting severity of eosinophilic esophagitis activity. Fifty patients received fractionated exhaled nitric oxide testing within 1 week of endoscopic evaluation with biopsy for determination of peak eosinophil counts. Presence of furrows was also evaluated with respect to FeNO levels. Spearman correlation was calculated between FeNO and peak eosinophil counts (PEC) with subgroup analysis performed based on PPI use. Spearman correlation was performed on the change in FeNO and PEC on the patients receiving repeat testing. FeNO was poorly correlated to PEC (Spearman correlation 0.22). With a cut-off FeNO value of > 40 ppb, specificity of FeNO for detecting presence of ≥ 15 eos/hpf was 0.94 and sensitivity was 0.16. FeNO showed weak relationship to presence of furrows. Within the subgroup of patients not taking PPI, the spearman correlation was 0.21. Delta- FeNO versus Delta-PEC had spearman correlation of 0.72 for patients receiving repeat testing. FeNO likely has limited clinical utility for predicting severity of esophageal eosinophilia. In patients with FeNO levels > 40 ppb, specificity of testing was high, but very few patients reached this FeNO level.

Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;147(6):1238–54. https://doi.org/10.1053/j.gastro.2014.07.055.CrossRefPubMed

Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(7):1451–9. https://doi.org/10.1053/j.gastro.2012.03.001.CrossRefPubMed

Lucendo AJ, Arias A, Gonzalez-Cervera J, Yague-Compadre JL, Guagnozzi D, Angueira T, Jimenez-Contreras S, Gonzalez-Castillo S, Rodriguez-Domingez B, De Rezende LC, Tenias JM. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131(3):797–804. https://doi.org/10.1016/j.jaci.2012.12.664.CrossRefPubMed

Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol. 2005;95(4):336–43. https://doi.org/10.1016/s1081-1206(10)61151-9.CrossRefPubMed

Henderson CJ, Abonia JP, King EC, Putnam PE, Collins MH, Franciosi JP, Rothenberg ME. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2012;129(6):1570–8. https://doi.org/10.1016/j.jaci.2012.03.023.CrossRefPubMedPubMedCentral

Philpott H, Nandurkar S, Royce SG, Gibson PR. Ultrathin unsedated transnasal gastroscopy in monitoring eosinophilic esophagitis. J Gastroenterol Hepatol. 2016;31(3):590–4. https://doi.org/10.1111/jgh.13173.CrossRefPubMed

Katzka DA, Geno DM, Ravi A, Smyrk TC, Lao-Sirieix P, Miremadi A, Debiram I, O’Donovan M, Kita H, Kephart GM, Kryzer LA, Camilleri M, Alexander JA, Fitzgerald RC. Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015;13(1):77–83. https://doi.org/10.1016/j.cgh.2014.06.026.CrossRefPubMed

Dellon ES, Rusin S, Gebhart JH, Covey S, Higgins LL, Beitia R, Speck O, Woodward K, Woosley JT, Shaheen NJ. Utility of a noninvasive serum biomarker panel for diagnosis and monitoring of eosinophilic esophagitis: a prospective study. Am J Gastroenterol. 2015;110(6):821–7. https://doi.org/10.1038/ajg.2015.57.CrossRefPubMedPubMedCentral

Mummadi SR, Hahn PY. Update on exhaled nitric oxide in clinical practice. Chest. 2016;149(5):1340–4. https://doi.org/10.1016/j.chest.2015.11.020.CrossRefPubMed

10.

Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–15. https://doi.org/10.1164/rccm.9120-11ST.CrossRefPubMedPubMedCentral

11.

Lanz MJ, Guerrero RA, Gonzalez-Vallina R. Measurement of exhaled nitric oxide in the evaluation for eosinophilic esophagitis in children. Ann Allergy Asthma Immunol. 2012;109(1):81–2. https://doi.org/10.1016/j.anai.2012.05.009.CrossRefPubMed

12.

Leung J, Nguyen-Traxler A, Lee EM, Yip JS, Weinstock JV, Chan WW, Ngo P, Weinstein BJ, Bonis PA. Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis. Allergy Asthma Proc. 2012;33(6):519–24. https://doi.org/10.2500/aap.2012.33.3606.CrossRefPubMedPubMedCentral

13.

Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62(4):489–95. https://doi.org/10.1136/gutjnl-2011-301817.CrossRefPubMed

14.

R core team (2017) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.

15.

Olin AC, Rosengren A, Thelle DS, Lissner L, Bake B, Toren K. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest. 2006;130(5):1319–25. https://doi.org/10.1378/chest.130.5.1319.CrossRefPubMed

16.

Scott M, Raza A, Karmaus W, Mitchell F, Grundy J, Kurukulaaratchy RJ, Arshad SH, Roberts G. Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study. Thorax. 2010;65(3):258–62. https://doi.org/10.1136/thx.2009.125443.CrossRefPubMed

17.

Rees DC, Satsangi J, Cornelissen PL, Travis SP, White J, Jewell DP. Are serum concentrations of nitric oxide metabolites useful for predicting the clinical outcome of severe ulcerative colitis? Eur J Gastroenterol Hepatol. 1995;7(3):227–30.PubMed

18.

Oudkerk Pool M, Bouma G, Visser JJ, Kolkman JJ, Tran DD, Meuwissen SG, Pena AS. Serum nitrate levels in ulcerative colitis and Crohn’s disease. Scand J Gastroenterol. 1995;30(8):784–8.CrossRefPubMed

19.

Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I, Higuchi H, Akiba Y, Hokari R, Hirokawa M, Serizawa H, Ishii H. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn’s disease. Dig Dis Sci. 1997;42(5):1047–54.CrossRefPubMed

20.

Rachmilewitz D, Eliakim R, Ackerman Z, Karmeli F. Direct determination of colonic nitric oxide level–a sensitive marker of disease activity in ulcerative colitis. Am J Gastroenterol. 1998;93(3):409–12. https://doi.org/10.1111/j.1572-0241.1998.00409.x.CrossRefPubMed

21.

Goggins MG, Shah SA, Goh J, Cherukuri A, Weir DG, Kelleher D, Mahmud N. Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease. Mediat Inflamm. 2001;10(2):69–73. https://doi.org/10.1080/09629350120054536.CrossRef

22.

Koek GH, Verleden GM, Evenepoel P, Rutgeerts P. Activity related increase of exhaled nitric oxide in Crohn’s disease and ulcerative colitis: a manifestation of systemic involvement? Respir Med. 2002;96(7):530–5.CrossRefPubMed

23.

Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9(3):179–89.CrossRefPubMed

24.

Ghebremariam YT, LePendu P, Lee JC, Erlanson DA, Slaviero A, Shah NH, Leiper J, Cooke JP. Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation. 2013;128(8):845–53. https://doi.org/10.1161/circulationaha.113.003602.CrossRefPubMed

Title: Poor Relationship Between Fractionated Exhaled Nitric Oxide and Disease Activity in Eosinophilic Esophagitis
Authors: Kimberly Johnson
Vivek Iyer
David Katzka
Karthik Ravi
Ryan Lennon
Richard Pendegraft
Debra Geno
Jeffrey Alexander
Publication date: 01-02-2019
Publisher: Springer US
Published in: Dysphagia / Issue 1/2019
Print ISSN: 0179-051X
Electronic ISSN: 1432-0460
DOI: https://doi.org/10.1007/s00455-018-9925-4

At a glance: The STEP trials

Springer Medicine

Poor Relationship Between Fractionated Exhaled Nitric Oxide and Disease Activity in Eosinophilic Esophagitis

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Psychometric Properties of Visuoperceptual Measures of Videofluoroscopic and Fibre-Endoscopic Evaluations of Swallowing: A Systematic Review

Improving the Diagnostic Capability of the Modified Barium Swallow Study Through Standardization of an Esophageal Sweep Protocol

Establishing a Multidisciplinary Head and Neck Clinical Pathway: An Implementation Evaluation and Audit of Dysphagia-Related Services and Outcomes

To Sweep or Not to Sweep

Tongue Shape Dynamics in Swallowing Using Sagittal Ultrasound

Medicine Administration in People with Parkinson’s Disease in New Zealand: An Interprofessional, Stakeholder-Driven Online Survey